Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Exchange Rate Effect (2019 - 2023)

Historic Exchange Rate Effect for AVITA Medical (RCEL) over the last 5 years, with Q4 2023 value amounting to -$1000.0.

  • AVITA Medical's Exchange Rate Effect fell 10227.27% to -$1000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$16000.0, marking a year-over-year increase of 5789.47%. This contributed to the annual value of -$16000.0 for FY2023, which is 3846.15% up from last year.
  • AVITA Medical's Exchange Rate Effect amounted to -$1000.0 in Q4 2023, which was down 10227.27% from -$18000.0 recorded in Q3 2023.
  • In the past 5 years, AVITA Medical's Exchange Rate Effect registered a high of $127000.0 during Q3 2020, and its lowest value of -$68000.0 during Q1 2020.
  • For the 5-year period, AVITA Medical's Exchange Rate Effect averaged around $5062.5, with its median value being -$3500.0 (2022).
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first skyrocketed by 67727.27% in 2020, then plummeted by 14330.71% in 2021.
  • Quarter analysis of 5 years shows AVITA Medical's Exchange Rate Effect stood at $48000.0 in 2019, then tumbled by 35.42% to $31000.0 in 2020, then crashed by 277.42% to -$55000.0 in 2021, then soared by 180.0% to $44000.0 in 2022, then tumbled by 102.27% to -$1000.0 in 2023.
  • Its Exchange Rate Effect was -$1000.0 in Q4 2023, compared to -$18000.0 in Q3 2023 and $2000.0 in Q2 2023.